How does your management and counseling of a patient with ovarian cancer change when they have significant persistent disease after neoadjuvant chemotherapy?

When a patient with ovarian cancer has a very poor response to neoadjuvant chemotherapy, how does your approach to interval debulking surgery change?

• I am more aggressive with debulking surgery than I might otherwise be
• It does not affect how aggressive I approach debulking surgery
• I am less aggressive with debulking surgery
• I would consider only palliative surgery in this case
• Other